v3.26.1
Business Combinations - Additional Information (Detail)
3 Months Ended 6 Months Ended
Oct. 07, 2025
USD ($)
NonTradableContingentValueRightCvrPerShare
$ / shares
Jun. 30, 2026
USD ($)
$ / shares
Jun. 30, 2026
USD ($)
$ / shares
Dec. 31, 2025
USD ($)
Business Acquisition [Line Items]        
Measurement period adjustments to acquired assets and liabilities   $ 0 $ 0  
Goodwill   $ 67,595,000 $ 67,595,000 $ 67,595,000
Incremental borrowing rate   7.60% 7.60% 7.60%
IPR&D        
Business Acquisition [Line Items]        
Fair value discount rate percent 23.00%      
Royalty rate percent 10.00%      
Developed Technology        
Business Acquisition [Line Items]        
Fair value discount rate percent 23.00%      
Royalty rate percent 10.00%      
scPharmaceuticals Inc.        
Business Acquisition [Line Items]        
Effective date of acquisition Oct. 07, 2025      
Acquisition price per share in cash | $ / shares $ 5.35      
Non-tradable contingent value right ("CVR") per share | NonTradableContingentValueRightCvrPerShare 1      
Amount per CVR in cash upon achievement of certain regulatory and net sales milestones | $ / shares $ 1      
Equity value $ 303,800,000      
Total purchase price 363,500,000      
Fair value changes   $ 5,000,000 $ 7,769,000  
Goodwill 65,700,000      
scPharmaceuticals Inc. | IPR&D        
Business Acquisition [Line Items]        
Recognized intangible asset 129,600,000      
scPharmaceuticals Inc. | Developed Technology        
Business Acquisition [Line Items]        
Recognized intangible asset $ 194,000,000      
scPharmaceuticals Inc. | Milestone 1 September 30, 2026        
Business Acquisition [Line Items]        
Amount per CVR in cash upon achievement of milestones | $ / shares   $ 0.75 $ 0.75  
scPharmaceuticals Inc. | Milestone 1 December 31, 2026        
Business Acquisition [Line Items]        
Amount per CVR in cash upon achievement of milestones | $ / shares   0.5 0.5  
scPharmaceuticals Inc. | Milestone 1 June 30, 2027        
Business Acquisition [Line Items]        
Amount per CVR in cash upon achievement of milestones | $ / shares   0.25 0.25  
scPharmaceuticals Inc. | Milestone 2        
Business Acquisition [Line Items]        
Amount per CVR in cash upon achievement of milestones | $ / shares   $ 0.25 $ 0.25  
Minimum milestone net sales     $ 110,000,000  
Net sales     120,000,000  
scPharmaceuticals Inc. | Milestone 1 July 23, 2026        
Business Acquisition [Line Items]        
Aggregate milestone payment achieved   $ 44,800,000 $ 44,800,000  
scPharmaceuticals Inc. | Maximum        
Business Acquisition [Line Items]        
Consideration per share in cash | $ / shares $ 6.35      
scPharmaceuticals Inc. | Maximum | Milestone 2        
Business Acquisition [Line Items]        
Amount per CVR in cash upon achievement of milestones | $ / shares   $ 0.25 $ 0.25  
Net sales     $ 120,000,000  
scPharmaceuticals Inc. | Minimum | Milestone 2        
Business Acquisition [Line Items]        
Amount per CVR in cash upon achievement of milestones | $ / shares   $ 0.1 $ 0.1  
Net sales     $ 110,000,000